ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04512	ECM-receptor interaction	16/159	79/7206	9.62231304213e-12
ko04974	Protein digestion and absorption	16/159	96/7206	2.14000389466e-10
ko04510	Focal adhesion	18/159	240/7206	4.9259756193e-06
ko05146	Amoebiasis	10/159	99/7206	5.94199427433e-05
ko04060	Cytokine-cytokine receptor interaction	13/159	191/7206	0.000287823863672
ko00120	Primary bile acid biosynthesis	4/159	20/7206	0.000839171354149
ko04151	PI3K-Akt signaling pathway	19/159	390/7206	0.00103427010846
ko00643	Styrene degradation	2/159	4/7206	0.0028195258738
ko00350	Tyrosine metabolism	4/159	33/7206	0.00567351178894
ko04670	Leukocyte transendothelial migration	9/159	151/7206	0.00604712042575
ko05410	Hypertrophic cardiomyopathy (HCM)	7/159	100/7206	0.00642161069289
ko05160	Hepatitis C	9/159	153/7206	0.00658002618595
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	6/159	79/7206	0.00775036746507
ko04514	Cell adhesion molecules (CAMs)	8/159	130/7206	0.00787240258862
ko05414	Dilated cardiomyopathy	7/159	112/7206	0.0116810790375
ko04640	Hematopoietic cell lineage	5/159	64/7206	0.01315103679
ko00565	Ether lipid metabolism	4/159	42/7206	0.0133194394436
ko04530	Tight junction	11/159	228/7206	0.0175517123561
ko00401	Novobiocin biosynthesis	1/159	1/7206	0.0220649458785
ko00130	Ubiquinone and other terpenoid-quinone biosynthesis	2/159	11/7206	0.0233500440568
ko04976	Bile secretion	5/159	80/7206	0.0313852294187
ko05203	Viral carcinogenesis	1/159	277/7206	0.0329224264976
ko04657	IL-17 signaling pathway	5/159	87/7206	0.0427412984887
ko04010	MAPK signaling pathway	2/159	321/7206	0.0491404440089